Results 121 to 130 of about 36,498 (214)

Kinetic and structural characterisation of domain‐specific angiotensin I‐converting enzyme inhibition by captopril, rentiapril and zofenoprilat

open access: yesThe FEBS Journal, Volume 293, Issue 11, Page 3399-3414, June 2026.
Angiotensin I‐converting enzyme (ACE) contains two catalytic domains (nACE and cACE) and is a key therapeutic target for hypertension and cardiovascular disease. Current ACE inhibitors (ACEi) nonselectively inhibit both domains, causing adverse effects. Selective inhibition requires an understanding of domain‐specific binding.
Kyle S. Gregory   +3 more
wiley   +1 more source

Modest Contribution of Bradykinin to Blood Pressure Reduction by Sacubitril/Valsartan in Chronic Heart Failure. [PDF]

open access: yesCirc Heart Fail
Gupta DK   +8 more
europepmc   +1 more source

Loss of Striatal Bradykinin B2 Receptor Alters Anxiety and Motivational Behaviors in Male Mice

open access: yesThe FASEB Journal, Volume 40, Issue 10, 31 May 2026.
Impaired signaling of the bradykinin B2 receptor (B2R) in dorsal striatal neurons decreases anxiety‐like behavior and sucrose preference while enhancing voluntary running in mice. These results reveal a novel role for B2R in dopaminergic circuits that modulate motivation and emotional behavior.
Mariana Rosolen Tavares   +5 more
wiley   +1 more source

Acquired Angioedema-A Challenge in Medical Practice: A Narrative Review. [PDF]

open access: yesJ Clin Med
Poznańska-Kurowska K   +4 more
europepmc   +1 more source

Glycocalyx strengthens endothelial barrier function and protects from angioedema inducing compounds. [PDF]

open access: yesFront Immunol
Reich A   +8 more
europepmc   +1 more source

Bradykinin [PDF]

open access: yes, 2019
openaire   +1 more source

Home - About - Disclaimer - Privacy